Vaccine Development Summary
#581
The FDA did not approve the vaccine yet, and they don't do it unilaterally. They have an independent panel review the data and make a recommendation, which the FDA then acts on, one way or another. So that's two checks on the mfg.
Max wouldn't have happened if the FAA had done just one check. Maybe they should adopt the pharma model.
#582
No the govt didn't approve the max, they let Boeing do it for them.
The FDA did not approve the vaccine yet, and they don't do it unilaterally. They have an independent panel review the data and make a recommendation, which the FDA then acts on, one way or another. So that's two checks on the mfg.
Max wouldn't have happened if the FAA had done just one check. Maybe they should adopt the pharma model.
The FDA did not approve the vaccine yet, and they don't do it unilaterally. They have an independent panel review the data and make a recommendation, which the FDA then acts on, one way or another. So that's two checks on the mfg.
Max wouldn't have happened if the FAA had done just one check. Maybe they should adopt the pharma model.
https://www.usatoday.com/story/news/...or/6488650002/
of course, it hasn’t been approved yet, and if it is only 70% effective, and not yet tested on anyone over age 55, approval may not be imminent. And if, by that time, two other vaccines are indeed 90%+ effective and have a head start, it may never be approved.
#583
Hmmm...
Not sure I know what to make of this....
https://www.bloomberg.com/news/artic...g-transmission
Gonna have to read the actual Lancet article. This news article implies that the AstraZeneca two shot vaccination is not very effective against a symptomatic spread:
Not sure I know what to make of this....
https://www.bloomberg.com/news/artic...g-transmission
Gonna have to read the actual Lancet article. This news article implies that the AstraZeneca two shot vaccination is not very effective against a symptomatic spread:
Oxford and Astra are the first vaccine developers to unveil data on asymptomatic infection rates in people who received their shot. Overall, it reduced such transmissions by 27% in a large study, according to peer-reviewed resultspublished in the Lancet medical journal on Tuesday.
That’s well below the vaccine’s 70% effectiveness at preventing symptomatic Covid-19 cases overall, though even those results are clouded by questions over its benefits in older recipients.
That’s well below the vaccine’s 70% effectiveness at preventing symptomatic Covid-19 cases overall, though even those results are clouded by questions over its benefits in older recipients.
#584
Gets Weekends Off
Joined APC: Sep 2014
Posts: 1,316
#585
Gets Weekends Off
Joined APC: Oct 2006
Position: Dream Job
Posts: 403
Sent from my BTV-W09 using Tapatalk
#586
Just read the full report. Lots of evidence that it works. Lots of evidence of adverse reactions also. The younger you are, the worse the side effects. It'll also be interesting to see if the Bell's palsy was caused by the vaccine or was it just bad luck of the vaccinated group.
Serious adverse reactions actually caused by the vaccine are pretty unlikely at this point, it probably would have been flagged by now. If you look at 100,000+ people there are going to be some medical issues. Probably a motorcycle fatality or two as well, doubtless caused by the vaccine.
#587
I don’t know. The stuff coming from the Astrazeneca studies is still a little...wonky.
https://www.usatoday.com/story/news/...or/6488650002/
of course, it hasn’t been approved yet, and if it is only 70% effective, and not yet tested on anyone over age 55, approval may not be imminent. And if, by that time, two other vaccines are indeed 90%+ effective and have a head start, it may never be approved.
https://www.usatoday.com/story/news/...or/6488650002/
of course, it hasn’t been approved yet, and if it is only 70% effective, and not yet tested on anyone over age 55, approval may not be imminent. And if, by that time, two other vaccines are indeed 90%+ effective and have a head start, it may never be approved.
I think they're going to specifically test the 90% regimen in a new large trail to be sure. Sounds like the managers did not know that the scientists were using different dosing in different subsets of the trial.
But 70% would be enough for US certification, assuming the ongoing US trial has produced adequate data to that effect.
Age range is irrelevant, pharma can be and routinely is approved for specific age ranges. It's then simply not legal for use by people outside that range.
#588
UAE reports good results (86% efficacy) from Sinopharm vaccine trial. This is not mRNA, but inactivated virus which is established vaccine technology.
https://www.npr.org/sections/coronav...-ministry-says
https://www.npr.org/sections/coronav...-ministry-says
#589
Worst blow to vaccine progress to date, anti-vaxxers can cheer now: Russia advises NO ALCOHOL consumption for two months after receiving Russian sputnik vaccine. That might be a problem... in Russia.
https://www.foxnews.com/health/coron...hol-two-months
https://www.foxnews.com/health/coron...hol-two-months
#590
FDX says they (and UPS) can handle vaccine logistics...
https://www.reuters.com/article/us-h...-idUSKBN28I39T
https://www.reuters.com/article/us-h...-idUSKBN28I39T
Thread
Thread Starter
Forum
Replies
Last Post